| Designing phase I oncology dose escalation using dose–exposure–toxicity models as a complementary approach to model‐based dose–toxicity models K Pantoja, S Lanke, A Munafo, A Victor, C Habermehl, A Schueler, ... CPT: Pharmacometrics & Systems Pharmacology 11 (10), 1371-1381, 2022 | 4 | 2022 |
